Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician December 15, 2002 Lecia M. Apantaku	Breast-Conserving Surgery for Breast Cancer Surgical treatment of breast cancer has changed significantly in recent years. The preferred method of treatment for many women with early breast cancer is conservative surgical therapy.
American Family Physician March 15, 2004	Breast Cancer Risk Related to Type of Hormone Therapy Although several studies have demonstrated an increased risk of breast cancer in postmenopausal women taking oral hormone therapy, the risk related to each of the various forms of therapy is less clear.
BusinessWeek June 6, 2005 Catherine Arnst	Better Odds Against Breast Cancer New treatments for breast cancer are more effective, and easier to live with
American Family Physician December 15, 2002	Breast-Conserving Surgery What is breast-conserving surgery?... How does my doctor know if my lump is cancer?... Why does my doctor check my lymph nodes?... What if I cannot have breast-conserving surgery?...
Nurse Practitioner December 2011 Downs-Holmes & Silverman	Breast cancer: Overview & updates This overview of breast cancer will discuss pathologic features, local and systemic treatment considerations, endocrine therapy, metastatic treatment regimens, and follow-up for optimal breast health.
Chemistry World March 4, 2011 Elinor Richards	Laser treatment for late-stage cancer Scientists from China, the US and Peru claim to have successfully treated late-stage breast cancer patients using laser immunotherapy to stimulate patients' own immune systems to fight the cancer.
Nurse Practitioner August 2010 Virginia Sun	Update on Pancreatic Cancer Treatment Pancreatic cancer is the 10th leading type of all new cancer cases and the fourth leading type of cancer death that affects both men and women.
Chemistry World June 12, 2012 Nina Notman	Three pronged approach puts brakes on US breast cancer The US Food and Drug Administration (FDA) has approved the use of anti-HER2 therapy Perjeta (pertuzumab) to treat patients with previously untreated HER2-positive metastatic breast cancer.
Managed Care August 2007 Thomas Morrow	Gene Expression Microarray Improves Prediction of Breast Cancer Outcomes Flash-frozen samples of surgically removed breast cancer tissue are the key to measuring a patient's risk of metastasis.
AskMen.com September 30, 2000 Joshua Levine	Male Breast Cancer Breast cancer is traditionally thought of as a female-related problem. Men, however, are as susceptible to the disease as women are. In many ways, the disease appears similarly in both sexes...
AskMen.com Sabrina Rogers	Can Men Get Breat Cancer? Breast cancer isn't just a chick thing. Although it is about 100 times more common among women and is a rare cause of death in men, the American Cancer Society estimates that, in 2004, approximately 1,450 American men will be diagnosed with this disease.
Salon.com June 20, 2000 Naomi Mendelsohn	Choosing the knife Healthy women at high risk for breast cancer are choosing to have both breasts removed, even while doctors are advocating less invasive treatments for those who are already sick
BusinessWeek May 23, 2005 Catherine Arnst	If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer.
American Family Physician August 1, 2000 Lecia M. Apantaku	Breast Cancer Diagnosis and Screening Statistics on breast cancer risk, symptoms and recommended tests.
American Journal of Nursing October 2010 Amy M. Collins	'Men Get Breast Cancer, Too!' Theron Bell has made raising public awareness of male breast cancer his life's work.
American Family Physician February 15, 2005 Sunga et al.	Care of Cancer Survivors Cancer survivors are at increased risk for recurrence of their original malignancy. Surveillance following curative cancer treatment generally includes interval history and physical examinations every six months for five years.
Nurse Practitioner October 2009 Wallace et al.	Shedding light on prostate cancer This article will discuss the risk factors, signs and symptoms, diagnosis of prostate cancer, and disease staging and grading, as well as necessary lab and diagnostic tests, treatment options and patient education.
BusinessWeek July 3, 2006 Catherine Arnst	A Ton Of Prevention The pros and cons of two drugs that may halve your risk of breast cancer.
Salon.com November 10, 2000 Laurie Tarkan	The business of breast cancer Big medicine is making big bucks on the disease, but we're still far from a cure...
American Family Physician December 15, 2002 Randhawa & Fink	Screening for Breast Cancer A case study and question-and-answer group on screening for breast cancer, based on the recommendations of the current U.S. Preventive Services Task Force
BusinessWeek September 5, 2005 Michael Arndt	Fine-Tuning the Attack on Breast Cancer Genentech's Herceptin, the first drug approved for a specific group, helps patients who are genetically susceptible to a virulent form of the disease.
The Motley Fool May 8, 2009 Brian Orelli	Investing Against Breast Cancer Many companies are interested in both a cure and a large lucrative market. Which are the best investments now in this sector?
Chemistry World September 7, 2015	Cancer Drugs Fund axes 23 treatments The Cancer Drugs Fund, which covers the cost of some cancer treatments that are not currently available on the National Health Service, has cut 23 treatments -- involving 16 drugs.
American Journal of Nursing October 2010 Eileen Thomas	Men's Awareness and Knowledge of Male Breast Cancer This article reports on the findings of a qualitative study that explored the awareness and knowledge of male breast cancer among English-speaking men.
Nurse Practitioner November 2010 Dreadin & Mancuso	Diagnostic breast evaluation: When to refer and what the results really mean Diagnostic breast imaging is an important tool in evaluating abnormal physical examination findings and assessing incomplete screening mammographic results.
The Motley Fool September 17, 2007 Brian Orelli	Preventing Cancer, No Bones About It For Eli Lilly, the only thing better than having a drug with more than $1 billion in annual sales is getting it approved to treat more patients. That's what just happened with their cancer drug, EVISTA. Investors, take note.
American Family Physician February 15, 2005	Health Care After Cancer Treatment An informative patient hand-out on follow-up cancer care.
American Family Physician October 1, 2000	Genetic Testing for Breast Cancer Risk: What Does It Mean to Me? What causes breast cancer?... What genes can cause breast cancer to be inherited?... What clues in my family history might show I've inherited a risk of breast cancer?... Does everyone who has family members with breast cancer have these mutated genes?... What should I do?...
Nursing Management June 2009 Zimmerman & Britton	Prevention Through Vigilance: Malignant Melanoma Management Nurses can play a critical role in the care of patients with melanoma by offering preventive education and support.
AFP eWire February 24, 2006	Secrets of Success from a Nonprofit Pioneer Nancy Brinker, founder and self-described veteran volunteer for the Susan G. Komen Breast Cancer Foundation shared her secrets of success: Harness the power of one... Go for grassroots... Change the culture... etc.
Managed Care January 2005 Sharon Baker	Breast Cancer Screening: Some Plans Do Better Than Others Some of the nation's best health plans are coming up with creative ways to encourage women to get mammograms.
Salon.com October 12, 1999 Damien Cave	Male mastectomy Not many men get breast cancer, but too few are aware of the risk.
Pharmaceutical Executive February 1, 2013 William Looney	In Cancer, Process Drives Progress Today's most important public health story is the advance in our understanding of the biology of cancer.
The Motley Fool December 6, 2007 Brian Lawler	Genentech Voted Down An FDA panel recommends against expanded use of Genentech's lead drug.
Nurse Practitioner July 2011 Kass-Wolff & Fisher	Menopause and the Hormone Controversy: Clarification or Confusion? Hormone therapy in perimenopause and menopause remains a controversial and often confusing management strategy for healthcare providers. To assist in providing women quality healthcare, recently published new guidelines help provide direction for NPs.
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck	From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition?
American Family Physician August 1, 2000	Screening Yourself for Breast Cancer Breast cancer is one of the most common cancers in women. Women more than 20 years of age should know the signs of breast cancer and the best ways to find it early. How do I perform a breast self-exam? When should I have my mammogram? Clinical Breast Exam. Ultrasound exam. Breast Biopsies.
Pharmaceutical Executive September 1, 2012 Robin Hertz	The Endless Treadmill of End-of-Life Care Bending the cost curve back to valuing the cycle of life.
Information Today	ebrary Offers Free Breast Cancer Searchable Information Center ebrary has announced that it has collaborated with librarians from other organizations to create an open access database of breast cancer publications in honor of the National Breast Cancer Awareness Month.
Pharmaceutical Executive December 1, 2010 Walter Armstrong	Cancer: On Target Once More Over the past year or two, a handful of Phase III failures, including megablockbusters like Avastin and Sutent in trials for all kinds of common tumors, indicate that targeted therapy is generally a blunt instrument.
Chemistry World August 30, 2013 Laura Howes	Nice rules against Afinitor The National Institute for Health and Care Excellence (Nice), which evaluates treatments based on cost effectiveness, has confirmed that patients with advanced breast cancer will not be prescribed the Novartis drug Afinitor (everolimus).
Scientific American March 2009 Elaine Schattner	A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment
American Family Physician December 15, 2005 Mark H. Ebell	Predicting the Risk of Recurrence After Surgery for Prostate Cancer Several clinical decision rules have addressed this question. The most widely validated score the PSA, clinical stage, and Gleason grade to predict recurrence, which is defined as a postoperative serum PSA of 0.4 ng per mL or higher, clinical evidence of recurrence, or the need for subsequent treatment.
Chemistry World June 25, 2013 Emma Stoye	NHS to offer breast cancer prevention drugs New guidelines for the UK National Health Service suggest that women at high risk of breast cancer should be offered a five-year course of tamoxifen or raloxifene to prevent the disease developing.
BusinessWeek May 9, 2005 Catherine Arnst	Genentech's Lessons For Big Pharma The biotech company focuses on science -- not marketing, acquisitions, or patents.
The Motley Fool January 11, 2006 M.D. Mitchell	TriPath: Portfolio Palliative? The medical imaging company isn't cheap, but it carries a healthy prognosis. The company's year-over-year quarterly earnings per share have risen for the past 13 quarters.
Managed Care March 2007 Martin Sipkoff	Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails.
Nutrition Action Healthletter March 1999 Bonnie Liebman	Pesticides and Breast Cancer Women with higher levels of the pesticide dieldrin in their blood have a greater risk of breast cancer, say researchers from the Centers for Disease Control and Prevention in Atlanta and elsewhere...
American Family Physician November 15, 2006 Wolff & Wilson	Putting Prevention into Practice Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
ifeminists October 29, 2002 Rondi Adamson	Re-Evaluating the Risk of Breast Cancer As breast cancer became a poster disease for feminism in the 1980s, the attention it began to receive took on unreasonable proportions. In short, the intensity of funding, publicity and research around breast cancer is not based on need. It is based on politics.